Haijun He

Dr. Haijun He


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2021 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
YYYan Yan
Yan Yan
BTBiao Tan
Biao Tan
FFFanyu Fu
Fanyu Fu
QCQianglong Chen
Qianglong Chen
WLWenlong Li
Wenlong Li
HHHaijun He
Haijun He
Objective: Physical exercise has obvious effects on bone loss, pain relief, and improvement of bone metabolism indexes in patients with osteoporosis, but currently lacks sufficient evidence. The aim of this systematic review and meta‐analysis was to synthesize and present the best available evidence on the effectiveness and safety of exercises in the treatment of primary osteoporosis.Methods: Publications pertaining to the effectiveness of exercise on bone mineral density (BMD), visual analog scores (VAS), and biochemical markers of bone metabolism in primary osteoporosis (POP) from PubMed, Cochrane Library, Embase, VIP, CNKI, and Wanfang Database were retrieved from their inception to April 2020.Results: A total of 20 studies with 1824 participants were included. The results of the meta‐analysis revealed that exercise therapy for lumbar spine and femoral neck BMD is statistically different from conventional therapy (lumbar spine BMD: SMD = 0.78, 95%CI: 0.46, 1.10, P < 0.00001, I2 = 85%; femoral neck BMD (SMD = 0.80, 95%CI: 0.34, 1.27, P = 0.0007, I2 = 88%), exercise therapy can significantly increase the lumbar spine BMD of patients with OP, especially in lumbar spine2‐4 BMD (SMD = 0.47; 95%CI: 0.20, 0.75; P = 0.0008; I2 = 69%). Compared with conventional treatment, kinesitherapy also has significant differences in alleviating the pain of POP patients (SMD = −1.39, 95%CI: −2.47,−0.31, P = 0.01, I2 = 97%). Compared with conventional therapy, kinesitherapy has no significant difference in improving biochemical markers of bone metabolism such as bone glaprotein (BGP) (SMD = 2.59, 95%CI:0.90, 4.28, P = 0.003, I2 = 98%), N‐terminal pro peptide of type I procollagen (PINP) (SMD = 0.77, 95%CI: −0.44 to 1.98, P = 0.21, I2 = 95%), serum phosphorus (SMD = 0.04, 95%CI: −0.13, 0.22, P = 0.61, I2 = 30%), alkaline phosphatase (ALP) (SMD = −0.08, 95%CI: −0.44, 0.27, P = 0.64, I2 = 76%), and serum calcium (SMD = 0.12, 95%CI: −0.18, 0.43, P = 0.42, I2 = 63%) in POP patients.Conclusions: Kinesitherapy significantly improved lumbar spine and femoral neck BMD, and relieve the pain of patients in the current low‐quality evidence. Additional high‐quality evidence is required to confirm the effect of exercise therapy on the biochemical markers of bone metabolism in POP patients.

15 October 2020 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
ZHZe‐Qing Huang
Ze‐Qing Huang
FFFan‐Yu Fu
Fan‐Yu Fu
WLWen‐Long Li
Wen‐Long Li
BTBiao Tan
Biao Tan
HHHaijun He
Haijun He
WCWeiheng Chen
Weiheng Chen
Objective: To investigate the application of treatment modalities for patients with osteonecrosis of the femoral head (ONFH) in mainland China.Methods: This cross‐sectional study was based on the online application of China Osteonecrosis of the Femoral Head Database (CONFHD). Between July 2016 to December 2018, the CONFHD program planned to recruit ONFH patients from 12 administrative areas across mainland China. Real‐world medical records of treatment regimens for these patients, including surgeries and prescriptions, were approved to upload to the CONFHD application for further analysis. The surgeries performed on these patients were classified into total hip arthroplasty and hip‐preserving procedures, and the latter was further classified into core decompression, bone grafting, and tantalum rod implantation. Prescription medications were classified into chemical medicine and Chinese herbal medicine (CHM); chemical medicine was further classified according to their chemical compounds, and CHM was classified according to therapeutic functions based on traditional Chinese medicine theory. Descriptive analysis was performed to summarize the application of different treatment regimens on the overall sample.Results: A total of 1491 patients (2381 hips) who fulfilled the protocol criteria were included. There were 1039 males and 452 females with a mean age of 47.29 ± 12.69 years. The causes of ONFH were alcoholism in 642 patients (43%), corticosteroid in 439 patients (29%), trauma in 239 patients (16%), and idiopathic ONFH in 171 patients (11%). Operative treatments (including total hip arthroplasty and hip‐preserving procedures) were performed on 49% of patients (43% of hips), chemical medicine therapy (including bisphosphonate, statins, and prostacyclin) was given to 37% of patients (37% of hips), and CHM was administrated to 72% of patients (75% of hips). The aforementioned interventions were not always used alone, since 47% of patients (52% of hips) received combined regimens with multiple interventions. Among hips treated by surgery, all hips with ARCO stage IV ONFH received THA (305 hips), and THA was also performed on 63 hips with stage II ONFH. Over half of hips with stage I (81%), II (91%), and III (92%) ONFH had received pharmacological treatments. Prostacyclin and bisphosphonate were the top two most prescribed medicines used alone. CHM therapies with multiple CHM functions were more commonly prescribed.Conclusion: Current treatment modalities for ONFH patients in mainland China include operative treatment, chemical medicine, and CHM. Combined regimens with different treatment modalities are common in real‐world clinical practices.

16 November 2024 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
TYTong-Jie Yang
Tong-Jie Yang
SSShi-Yi Sun
Shi-Yi Sun
LZLei Zhang
Lei Zhang
XZXing-Ping Zhang
Xing-Ping Zhang
HHHaijun He
Haijun He
Osteonecrosis of the femoral head (ONFH) is a progressive and debilitating condition characterized by the death of bone tissue due to inadequate blood supply. Despite advances in diagnostic imaging and treatment strategies, predicting the risk of femoral head collapse remains a significant clinical challenge. This study seeks to address this gap by developing a robust prognostic model that integrates clinical, imaging, and laboratory data to improve early diagnosis and guide therapeutic decision-making. We conducted a qualitative systematic review and employed the Delphi method to select key prognostic factors from clinical data, imaging findings, and laboratory indicators. The study included ONFH patients treated from January 2014 to December 2021. We used univariate and multivariate Cox regression analyses to develop a nomogram for predicting the risk of femoral head collapse. The model’s performance was evaluated using the concordance index (C-index), calibration plots, and decision curve analysis (DCA). The study included 297 patients (454 hips) with ONFH. Key prognostic factors identified included pain presence (p < 0.001, RR = 0.185, 95% CI: 0.11–0.31), JIC classification (C1: p < 0.001, RR = 0.096, 95% CI: 0.054–0.171; C2: p < 0.001, RR = 0.323, 95% CI: 0.215–0.487), necrotic area (3 < MNAI < 6: p < 0.001, RR = 0.107, 95% CI: 0.061–0.190; MNAI ≥ 6: p < 0.001, RR = 0.466, 95% CI: 0.314–0.692), weight-bearing reduction (p < 0.001, RR = 0.466, 95% CI: 0.323–0.672), preservation of the anterolateral pillar (p < 0.001, RR = 0.223, 95% CI: 0.223–0.473), and subchondral bone fracture on CT (p < 0.001, RR = 0.32, 95% CI: 0.217–0.472). The nomogram demonstrated a high C-index of 0.88, indicating excellent predictive accuracy. Calibration plots showed good agreement between predicted and observed outcomes, and DCA confirmed the model’s clinical utility. The prognostic model developed in this study provides a reliable tool for predicting femoral head collapse in ONFH patients. It allows for early identification of high-risk patients, guiding personalized treatment strategies to improve patient outcomes and reduce the need for invasive surgical procedures.

10 August 2024 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
CZCheng Zhang
Cheng Zhang
BXBinglang Xiong
Binglang Xiong
JWJunyu Wang
Junyu Wang
YLYan Li
Yan Li
BXBin Xie
Bin Xie
HHHaijun He
Haijun He
Despite hip function typically deteriorating in the post-collapse stage of osteonecrosis of the femoral head (ONFH), some patients can still demonstrate long-term favorable hip function, a state termed “survival with collapse”. This study aims to identify the characteristics of patients suitable for “survival with collapse” in cases of ONFH. This cross-sectional study included 65 patients (87 hips) diagnosed with post-collapse ONFH for ≥ 3 years (average 9.1 years, range 3–23 years). Hip function was assessed using the Harris Hip Score (HHS). Demographic, clinical, and radiographic data were compared between the favorable group (HHS > 80) and the poor group (HHS ≤ 80). Independent protective factors for hip function were identified by multivariate analysis and receiver operating characteristic (ROC) curve analysis was further applied to evaluate these factors’ diagnostic efficacy. The favorable and poor groups included 46 and 41 hips, respectively. Significant differences were found in body mass index (BMI), Association Research Circulation Osseous (ARCO) stage, collapse degree, Japanese Investigation Committee (JIC) classification, necrotic size, and hip subluxation between the two groups (p < 0.05). Multivariate logistic regression identified collapse < 3 mm(OR:14.49, 95%CI: 3.52–59.68, p < 0.001), JIC types B (OR: 11.08, 95% CI: 1.07-115.12, p < 0.05) and C1(OR: 5.18, 95% CI: 1.47–18.20, p < 0.05) as independent protective factors for hip function, while BMI (OR: 0.76, 95% CI: 0.59–0.97, p = 0.029) was an independent risk factor. ROC curve analysis demonstrated that both collapse degree (AUC = 0.798, sensitivity = 91.3%, specificity = 68.3%, p < 0.0001) and JIC classification (AUC = 0.787, sensitivity = 80.4%, specificity = 73.2%, p < 0.0001) had satisfactory diagnostic value for hip function. Combining JIC classification and collapse degree (AUC = 0.868, sensitivity = 76.1%, specificity = 85.4%, p < 0.0001) significantly enhanced diagnostic efficacy compared to using either alone (p < 0.05). In ONFH, femoral head collapse does not necessarily determine a poor prognosis. Patients with mild collapse (< 3 mm) and preserved anterolateral wall are more likely to retain satisfactory hip function, making them candidates for “survival with collapse.”

17 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TYTong-Jie Yang
Tong-Jie Yang
YLYan Li
Yan Li
PWPeng-Peng Wen
Peng-Peng Wen
ZWZi-Xuan Wu
Zi-Xuan Wu
XYXin Ye
Xin Ye
HHHaijun He
Haijun He
This study aims to utilize Color Doppler Ultrasound to collect blood flow parameters of the medial circumflex femoral artery and explore the changes in blood flow in osteonecrosis of the femoral head, providing objective indicators for clinical assessment and prognosis. Color Doppler Ultrasound was used to examine the medial circumflex femoral artery in 30 patients with osteonecrosis of the femoral head (52 hips: ARCO Stage I—2 hips, Stage II—24 hips, Stage III—24 hips, Stage IV—2 hips) and 30 healthy controls (57 hips). Arterial diameter and blood flow parameters [peak systolic velocity, resistance index, pulsatility index] were collected and analyzed for vascular and blood flow characteristics in osteonecrosis of the femoral head. (1) Compared with the healthy group, the osteonecrosis group showed significantly lower peak systolic velocity and resistance index, while no significant differences were observed in arterial diameter and pulsatility index. (2) Arterial diameter in Stage I was significantly larger than in Stages II, III, and IV, with no significant differences observed among Stages II, III, and IV. Peak systolic velocity, resistance index, and pulsatility index all significantly decreased with disease progression from Stage I to Stage IV, but no significant difference in pulsatility index was found between Stages II and III. (3) There was no significant difference in arterial diameter between the non-collapsed and collapsed groups; however, peak systolic velocity, resistance index, and pulsatility index were all significantly lower in the collapsed group compared to the non-collapsed group. (1) The alterations in blood supply in femoral head necrosis primarily manifest as changes in blood flow parameters. (2) Vascular morphology and blood flow parameters could potentially be useful indicators for assessing the progression of femoral head necrosis. (3) Changes in blood flow parameters may provide valuable insights into the risk of femoral head collapse.

11 July 2025 in Medicine
Verified
Journal Article
Open access
CZCheng Zhang
Cheng Zhang
BXBinglang xiong
Binglang xiong
TYTong-jie Yang
Tong-jie Yang
TTTianzhao Tian
Tianzhao Tian
RWRongtian Wang
Rongtian Wang
WCWeiheng Chen
Weiheng Chen
Accumulating evidence from observational studies indicated that sarcopenia and osteoarthritis (OA) may interact in pathomechanism. Therefore, the present 2-sample Mendelian randomization (MR) study aimed to reveal the bidirectional causal association between sarcopenia-related traits and OA. We extracted instrumental variables strongly associated with sarcopenia-related traits, namely low grip strength, appendicular lean mass, and usual walking pace from 3 large-scale genome-wide association studies involving 256,523, 450,243, and 459,915 individuals, respectively. Summary-level data for knee and hip OA were obtained from a genome-wide association studies meta-analysis conducted by the UK Biobank and arcOGEN, involving 455,221 individuals of European descent. The inverse-variance weighted (IVW) method was utilized as primary MR analysis, whereas the weighted median, MR-Egger regression, and MR pleiotropy residual sum and outlier (MR-PRESSO) were performed as complementary methods to verify the robustness of findings. Our findings indicated genetically predicted usual walking pace was inversely associated with hip OA (IVW OR = 0.30, 95 CI = 0.17–0.53, P = 4.27 × 10−5) as well as knee OA (IVW OR = 0.20, 95 CI = 0.12–0.33, P = 1.07 × 10−9). In the reverse MR analyses, genetically predicted hip OA (IVW beta = −0.027, 95 CI = −0.038, −0.016, P = 6.83 × 10−7) demonstrated a negative causal effect on usual walking pace, while knee OA (IVW beta =0.002, 95 CI = −0.031 to 0.035, P = .898) did not show a significant effect. However, no evidence was found to suggest a causal effect of low grip strength and appendicular lean mass on hip or knee OA, and vice versa. Our study suggests a negative causal effect of usual walking pace, a sarcopenia-related traits, on knee and hip OA, with hip OA also negatively affecting walking pace. Further research is needed to explore the mechanisms linking sarcopenia-related traits and site-specific OA, aiming to identify common therapeutic targets.